Mainz Biomed N.V. Ordinary Shares (MYNZ) is a publicly traded Healthcare sector company. As of May 21, 2026, MYNZ trades at $0.84 with a market cap of $10.56M and a P/E ratio of -0.50. MYNZ moved +5.07% today. Year to date, MYNZ is -47.57%; over the trailing twelve months it is -81.89%. Its 52-week range spans $0.55 to $16.04. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces MYNZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Mainz Biomed N.V. Ordinary Shares (MYNZ) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MYNZ moved +5.07% today. Analyst consensus is hold.
| Metric | Value |
|---|---|
| Price | $0.84 |
| Market Cap | $10.56M |
| P/E Ratio | -0.50 |
| EPS | $-1.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.04 |
| 52-Week Low | $0.55 |
| Volume | 5.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $537.08K |
| Net Income | $-16.29M |
| Gross Margin | 0.00% |
3 analysts cover MYNZ: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.